We found that the biomarker combination with the highest classification accuracy consisted of ALX3, NPTX2, and TRIM58, which could achieve an average accuracy of 93.3% for the original five low five-year survival rate cancers and the other five additional common cancers (breast, colorectal, prostate, bladder, and stomach cancers). This evidence concerns the gene NPTX2 and gastric neoplasm.